SICKLE CELL CONSORTIUM INC (EIN 474771677) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2013

Legal Domicile

Principal Officer

LAKIEA BAILEY

Phone

7068253487

Tax Period

2023-01-01 to 2023-12-31

SICKLE CELL CONSORTIUM INC, founded in 2013, is a small nonprofit in the Health Care sector that reported $918K in total revenue in fiscal year 2023. Revenue surged 34% from the prior year, signaling strong growth momentum. Expenses of $1.0M exceeded revenue, resulting in a 11% operating deficit.

Mission

To provide sickle cell community-based organizations (CBOs) with the necessary infrastructure, support, training and resources.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $918,223

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $918,223

Expense Breakdown

Grants Paid $12,453

Salaries & Benefits $103,996

Fundraising Expenses $0

Program Expenses $831,228

Other Expenses $902,778

TOTAL EXPENSES $1,019,227

Year-over-Year Comparison

	2023	2022	Change
Revenue	$918,223	$686,666	+0.3%
Expenses	$1,019,227	$742,697	+0.4%
Net Income	$-101,004	$-56,031	+0.8%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$100,666

Total Directors

$100,666

Key Employees

$103,966

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
LAKIEA BAILEY	EXECUTIVE DIRECTOR	160	Officer Director Key Emp	$53,133	$0	$53,133
DORIS BAILEY	ASSOCIATE FINANCE DIRECTOR	160	Officer Director Key Emp	$25,900	$0	$25,900
RAMONA HOLLOWAY LAWRENCE	DIRECTOR OF RESEARCH	30	Officer Director Key Emp	$6,333	$0	$6,333
MIA ROBINSON	PRESIDENT OF THE GENERAL ASSEMBLY	30	Key Emp	$3,300	$0	$3,300
SHARONDA HUDSON	DIRECTOR OF OPERATIONS	160	Officer Director Key Emp	$15,300	$0	$15,300
ERIC NTI FREMPONG	DIRECTOR OF FINANCE	10	Officer Director Key Emp	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$918,223	$1,019,227	$124,212	$-101,004
2022	$686,666	$742,697	$190,766	$-56,031
2021	$681,362	$538,172	$246,797	$143,190
2020	$347,929	$244,322	$103,607	$103,607
2019	$325,000	$325,000	No data	No data
2018	$241,381	$241,381	No data	No data

SICKLE CELL CONSORTIUM INC